BIO STILOGIT PHARMACEUTIC
IPB-3 30 TABLETS
IPB-3 30 TABLETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
IPB-three
IBP-tre exerts its action thanks to the synergistic combination of three principles: Pinus pinaster, Urtica dioica and Serenoa repens.
Nettle and Saw Palmetto promote prostate function.
Ingredients
Maritime pine extract (Pinus pinaster Aiton) titrated at 90% in proanthocyanidins, saw palmetto extract (Serenoa repens Small.) titrated at 25% in fatty acids, nettle extract (Urtica urens L./Urtica dioica) titrated at 0.4% in beta-sitosterols.
Gluten free.
Lactose free.
How to use
Take 1 tablet daily.
Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Do not take during pregnancy.
Use is not recommended in women of childbearing age and in pre-pubertal subjects of either sex.
Format
Box of 30 tablets
BIO STILOGIT PHARMACEUTIC
IPB-3 30 TABLETS
IPB-3 30 TABLETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
